Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

636
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
636
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

842
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
842
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

2.7K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
2.7K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

2.0K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.0K
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

562
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
562
Nociception01:44

Nociception

27.6K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional Brain Localization of Botulinum Toxin Type A-Truncated Synaptosomal-Associated Protein 25 After Injection into the Rat Hind Paw.

Toxins·2026
Same author

Intrathecal monovalent fragments from two human monoclonal antibodies block tetanus neurotoxin in rodents.

iScience·2025
Same author

Celebrating the career of professor Zdravko Lacković: a life in neuroscience, pharmacology, and discovery.

Journal of neural transmission (Vienna, Austria : 1996)·2025
Same author

Experimental Parkinsonism induced by tetanus toxin injected into basal ganglia.

British journal of pharmacology·2025
Same author

Native botulinum toxin type A vs. redesigned botulinum toxins in pain: What did we learn so far?

Current opinion in pharmacology·2024
Same author

Mirror-Image Pain Update: Complex Interactions Between Central and Peripheral Mechanisms.

Molecular neurobiology·2024

Related Experiment Video

Updated: May 20, 2025

Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord
08:41

Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord

Published on: May 12, 2018

18.0K

Botulinum Toxin Type A Exerts Direct Trans-Synaptic Action at Bilateral Spinal Nociceptive Circuits.

Dalia Nemanić1, Petra Šoštarić2,3, Patrik Meglić2

  • 1Department of Pharmacology, University of Zagreb Faculty of Pharmacy and Biochemistry, A. Kovačića 1, 10 000 Zagreb, Croatia.

Toxins
|March 26, 2025
PubMed
Summary

Botulinum toxin type A (BoNT-A) provides pain relief on both sides of the body after a single injection. This study shows BoNT-A travels between nerves in the spinal cord to achieve this bilateral analgesic effect.

Keywords:
botulinum toxin type Ac-Fos immunohistochemistrycarrageenan-induced bilateral inflammatory painneutralizing antitoxinsynaptosomal-associated protein 25trans-synaptic transport

More Related Videos

Measuring Spinal Presynaptic Inhibition in Mice By Dorsal Root Potential Recording In Vivo
09:48

Measuring Spinal Presynaptic Inhibition in Mice By Dorsal Root Potential Recording In Vivo

Published on: March 29, 2014

13.9K
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

48.0K

Related Experiment Videos

Last Updated: May 20, 2025

Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord
08:41

Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord

Published on: May 12, 2018

18.0K
Measuring Spinal Presynaptic Inhibition in Mice By Dorsal Root Potential Recording In Vivo
09:48

Measuring Spinal Presynaptic Inhibition in Mice By Dorsal Root Potential Recording In Vivo

Published on: March 29, 2014

13.9K
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

48.0K

Area of Science:

  • Neuroscience
  • Pain Research
  • Pharmacology

Background:

  • Botulinum toxin type A (BoNT-A) is known to produce bilateral pain relief after unilateral injection.
  • The mechanism for this effect, whether indirect or direct central action, remains unclear.

Purpose of the Study:

  • To investigate the role of trans-synaptic toxin traffic in the bilateral analgesic effect of BoNT-A.
  • To determine if BoNT-A acts directly within the central nervous system to produce contralateral pain relief.

Main Methods:

  • Rats received unilateral intraplantar BoNT-A followed by bilateral hind-paw inflammation.
  • A neutralizing antitoxin was administered intrathecally to block spinal trans-synaptic toxin traffic.
  • Neuronal activation (c-Fos) and SNAP-25 cleavage were assessed in the dorsal horn.

Main Results:

  • Intrathecal antitoxin administration abolished the bilateral analgesic effect of BoNT-A.
  • BoNT-A treatment reduced c-Fos expression and SNAP-25 cleavage in the bilateral dorsal horn.
  • These findings indicate a central, trans-synaptic mechanism of action.

Conclusions:

  • BoNT-A exerts a direct contralateral analgesic action in bilateral pain models.
  • The pain-relieving efficacy of BoNT-A relies on its central trans-synaptic traffic.
  • BoNT-A acts on propriospinal nociceptive circuits for pain relief.